APO 117

Pill imprint APO 117 has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; hyperhidrosis; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.

Terazosin 5 mg is not subject to the Controlled Substances Act.
See also related documents.

Terazosin hydrochloride Images

Imprint:
APO 117
Strength:
5 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0117
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-5652 Major Pharmaceuticals
23490-6814 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Terazosin hydrochloride 5 mg APO 117  Front
Terazosin hydrochloride 5 mg APO 117  Back
Terazosin hydrochloride 5 mg APO 117
Terazosin hydrochloride 5 mg APO 117
Advertisement

Terazosin Hydrochloride is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web1)